View item

US Department of Defense – Parkinson's Research Program - Early Investigator Research Award
Sponsor: US Department of Defense 		Closing Date: 09-Jul-2019
The Parkinson’s Research Program (PRP) challenges the scientific community to develop impactful research that will advance the understanding of, and ultimately end, Parkinson’s disease. To be considered for funding, applications for the FY19 PRP Early Investigator Research Award (EIRA) must address at least one of the following FY19 PRP Focus Areas:

• Clinical and research application of digital health technology for Parkinson’s disease monitoring, including early identification
• Mechanisms of non-motor symptoms of Parkinson’s disease from basic biology to clinical application
• Sleep biology in Parkinson’s disease
• Quantifiable gene – environment interactions and the risk of Parkinson’s disease

The PRP EIRA supports Parkinson’s disease-focused research opportunities for individuals in the early stages of their careers, under the guidance of a designated Mentor. The Early Investigator is considered the Principal Investigator (PI) of the application and must exhibit strong potential for, and commitment to, pursuing a career as an investigator at the forefront of Parkinson’s disease research; however, the PI is not required to have previous Parkinson’s disease research experience. Applications must include at least one Mentor, appropriate to the proposed research project, who has experience in Parkinson’s disease research and mentoring as demonstrated by a record of active funding, recent publications, and successful mentorship. The selected Mentor(s) should also demonstrate a clear commitment to the development of the PI toward independence as a Parkinson’s disease researcher.

Key Dates
Pre-applications due to UQ R&I: 2 July 2019
Pre-applications (mandatory) close with US Department of Defense: 9 July 2019
Full applications due to UQ R&I: 10 July 2019
Full applications close with US Department of Defense: 24 July 2019
Confidential Letters of Recommendation Submission Deadline: 29 July 2019

Overview

Key Mechanism Elements
• Submission of a Letter of Intent is required prior to full application submission
• Supports early-career investigators who have innovative, high-impact ideas or new technologies applicable to Parkinson’s disease research and/or patient care
• PIs must have a designated mentor who is an experienced Parkinson’s disease researcher
• Must address as least one of the FY19 PRP Focus Areas
• Preliminary data are not required
• Clinical trials are not allowed

Eligibility
The investigator must be a postdoctoral or clinical fellow, instructor, or assistant professor within 10 years of advanced degree or residency training completion (or equivalent) as of the application deadline.

Funding
• Maximum funding of USD $360,000 for total costs (includes direct and indirect costs)
• Maximum period of performance is 2 years

How to Apply
Step 1. Completing the application
Please see the US Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at https://cdmrp.army.mil/funding/prp and https://cdmrp.army.mil/prp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Step 2. UQ R&I internal review and feedback
Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au.

Interested applicants are strongly encouraged to make contact with the UQR&I international team (via internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: https://cdmrp.army.mil/funding/prp

Return